FDA Endorses Johnson & Johnson Single-Shot Covid-19 Vaccine

FDA Endorses Johnson & Johnson Single-Shot Covid-19 Vaccine

The FDA has officially cleared the way for a third Coronavirus vaccine in the U.S.

A third vaccine to protect against Covid-19 could be entering the marketplace after the Food and Drug Administration endorsed Johnson & Johnson’s single-shot vaccine for emergency use on February 24.

The FDA staff said the data from the Johnson & Johnson clinical trials was “consistent with the recommendation set forth in FDA’s guidance Emergency Use Authorization for Vaccines to Prevent COVID-19.”

Johnson & Johnson submitted its Covid-19 vaccine data to the FDA on Feb. 4. The vaccine’s level of protection varied by region, with the shot demonstrating 66 percent effectiveness overall, 72 percent in the United States, 66 percent in Latin American and 57 percent in South Africa (where the B.1.351 variant is rapidly spreading).

The company said the vaccine prevented 100 percent of hospitalizations and deaths. As of Feb. 5, there were seven Covid-19 deaths in the study in the placebo group and no Covid-19 related deaths in the vaccine group, according to the FDA.

The FDA staff report, where the Johnson & Johnson vaccination was endorsed, is meant to brief the FDA’s Vaccines and Related Biological Product Advisory Committee, which will meet Friday to review J&J’s request for emergency use authorization.

During similar requests by Pfizer and Moderna, the agency authorized those companies’ vaccinations one day after the committee outside medical advisors backed emergency use authorization. The committee is expected to recommend Johnson & Johnson’s vaccine.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - May 2022

    May 2022

    Featuring:

    • WEARABLE TECHNOLOGY
      How Wearable Technology is Transforming Safety and the Industrial Workplace
    • TRAINING: CONFINED SPACES
      Five Tips to Improve Safety in Confined Spaces
    • INDUSTRIAL HYGIENE
      Monitor for Asbestos to Help Save Lives
    • PPE: FALL PROTECTION
      Fall Protection Can Be Surprising
    View This Issue